Follow the Astrana Health, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was reported on 18 August 2026 (Levée d'options). Among the most active insiders: Kumar Dinesh M.. The full history is openly available.
94
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€11m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Astrana Health, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
42Σ signal
Buys n/a€11m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,319 of 29,056 companies
17.1
score / 100
Value
24
Quality
10
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn0.0%
Net mgn-4.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
5,102 shares@ US$24.814.9% of flowCommon StockSEC:0001104659-26-000806:0
25 of 94 declarations
About Astrana Health, Inc.
Astrana Health, Inc. is a company listed on the XNAS market. It focuses on the healthcare sector, providing innovative solutions to enhance patient well-being.